Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Gene Technology Signs Partnership Agreement With Schott Nexterion

NEW YORK, July 8 (GenomeWeb News) - Oxford Gene Technology announced this week that it has signed a partnership agreement with Schott Nexterion to serve as a reference site for its glass substrates for oligonucleotide microarraying.


"Our partnership with OGT strengthens our company's research and development capabilities by combining our knowledge of surface chemistries and glass slides with OGT's expertise in the development of new array technologies to generate high quality oligonucleotide microarrays," said Lutz Wehmeier, Schott Nexterion's general manager.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.